NCT02182700View on ClinicalTrials.gov

Efficacy and Safety of Combivent® Aerosol and Spacer, in Adult Patients With Moderate to Severe Asthma Crisis

PHASE3TerminatedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

July 31, 1998

Primary Completion Date

December 31, 1999

Conditions
Asthma
Interventions
DRUG

salbutamol sulfate + ipratropium bromide

120 mcg (salbutamol sulfate) + 20 mcg (ipratropium bromide), inhalation (metered aerosol plus spacer)

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY